对Huperzine A衍生物进行研究,这些衍生物可以扩大对人体中毒的保护
Yalan Cui1, Xuejun Chen1, Jingjing Shi1
1State Key Laboratory of NBC Protection for Civilian, Beijing 102205, PR China.
Toxicology and applied pharmacology
|July 30, 2023
概括
新的huperzine A衍生物通过抑制乙胆化酶提供了对神经毒素的扩展保护. 这些化合物比现有的治疗方法具有较低的毒性和更持久的效果.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
背景情况:
- 胡素A (Hup A) 通过抑制乙胆化酶 (AChE) 来防止神经毒剂 (NA) 毒害.
- Hup A 的半衰期很短,这限制了它对 NA 暴露的长期预防效果.
研究的目的:
- 设计和合成具有扩展保护作用的新型Hup A衍生物,防止NA诱导的毒性.
- 评估这些新化合物的体外和体内疗效和毒性.
主要方法:
- 分子对接被用来评估42个设计的Hup A衍生物与ACHE的结合亲和力.
- 合成了6种有前途的衍生物,并使用埃尔曼方法确定了它们的ACHE抑制活性.
- 在小鼠体内研究评估了对 soman 和急性口服毒性的保护能力.
主要成果:
- 所有合成的衍生品都表现出度依赖的ACHE抑制,IC50值高于Hup A.
- 使用衍生品的预处理显著增强了对 soman 毒性的保护.
- 与Hup A.相比,一些衍生品 (H3,H4,H14,H16,H25) 在体内表现出长时间的保护作用.
- 新型化合物显示出比Hup A.更低的急性口服毒性.
结论:
- 设计的Hup A衍生品为开发抗神经毒剂的长效预处理剂提供了一个有前途的战略.
- 这些衍生物可能通过体内转化为Hup A.进行扩展保护.
- 改善的疗效和降低的毒性概况使这些化合物对NA对策具有价值.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
921
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
921
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
606
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
606
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.3K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.3K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.0K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.3K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.3K


